The FDA is evaluating unpublished new findings by a group of academic researchers that suggest an increased risk of panc…
Byetta
EU Approves Type 2 Diabetes Drug Byetta for Use with Basal Insulin
The European Commission has granted marketing authorization to Byetta (exenatide twice-daily) as an adjunctive therapy t…
Type 2 Diabetes Drug Byetta Recommended as Add-on Therapy to Insulin
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinio…
FDA Approves Byetta for Use with Lantus Insulin in the U.S.
The U.S. Food and Drug Administration (FDA) has approved a new use for Amylin and Eli Lilly's type 2 diabetes drug, Byet…
Victoza Found More Effective Than Byetta and Januvia In Treatment of Type 2 Diabetes
New data from two extension studies presented by Novo Nordisk at the 71st Annual Scientific Sessions of the American Dia…
Adding Byetta to Diabetes Treatment May Reduce Risk Of Heart Failure
Results from a retrospective analysis of more than 778,000 patients showed the addition of Byetta (exenatide) injection …
Amylin Files Lawsuit Against Eli Lilly Over Type 2 Diabetes Drug
Amylin Pharmaceuticals announced that it has filed a lawsuit against Eli Lilly. Amylin alleges Lilly is engaging in ant…
Positive Results for Once Monthly Type 2 Diabetes Drug
Positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exen…
Amylin and Eli Lilly Seek FDA approval for Expanded Use of Byetta in Type 2 Diabetes Patients
Amylin Pharmaceuticals, Inc.and Eli Lilly and Company have submitted a supplemental New Drug Application (sNDA) to the F…
Byetta (Exenatide) and Insulin Combination Produces Best Result in Type 2 Diabetes Patients
Combining the diabetes drug exenatide (Byetta) with insulin provides better blood sugar control in patients with type 2 …
